Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

3.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
3.0K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

5.8K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.8K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

7.3K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.3K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

8.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
8.3K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

926
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
926

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Gad et al. Management of Childhood Obesity. <i>Int. J. Mol. Sci.</i> 2026, <i>27</i>, 3528.

International journal of molecular sciences·2026
Same author

Case Report: Effect of setmelanotide treatment in a young patient with acquired hypothalamic obesity following <i>Escherichia coli</i> sepsis and meningoencephalitis with brain abscess.

Frontiers in endocrinology·2026
Same author

Effect of dual hepatic and portal vein embolization on future liver remnant function and volume prior to major hepatectomy.

Annals of hepato-biliary-pancreatic surgery·2026
Same author

Distal ureterectomy versus radical nephroureterectomy for nonmetastatic distal ureteral urothelial carcinoma: a GRADE-assessed systematic review and meta-analysis of comparative studies.

World journal of surgical oncology·2026
Same author

Zaleya pentandra L. produces anti-arthritic effects by downregulating IL-6, NF-κB, and TNF-α and mitigating oxidative stress.

Inflammopharmacology·2026
Same author

Ethnobotanical survey of medicinal plants traditionally used in Daulat Nagar, Punjab, Pakistan.

Journal of ethnobiology and ethnomedicine·2026

Related Experiment Video

Updated: Mar 22, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

96.1K

Hyperinsulinemic Hypoglycemia - The Molecular Mechanisms.

Azizun Nessa1, Sofia A Rahman1, Khalid Hussain1

  • 1Genetics and Genomic Medicine Programme, Department of Paediatric Endocrinology, UCL Institute of Child Health, Great Ormond Street Hospital for Children NHS , London , UK.

Frontiers in Endocrinology
|April 12, 2016
PubMed
Summary

Hyperinsulinemic hypoglycemia (HH) occurs when pancreatic beta-cells secrete excess insulin, causing low blood glucose. This review details the molecular defects in genes and other factors leading to unregulated insulin secretion in HH.

Keywords:
KATP channelscongenital hyperinsulinismglucosehyperinsulinemic hypoglycemiainsulin

More Related Videos

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.3K
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

11.0K

Related Experiment Videos

Last Updated: Mar 22, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

96.1K
Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.3K
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

11.0K

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Genetics

Background:

  • Pancreatic beta-cells normally regulate insulin secretion to maintain blood glucose homeostasis (3.5-5.5 mmol/L).
  • Hyperinsulinemic hypoglycemia (HH) is characterized by inappropriate insulin secretion during hypoglycemia.
  • HH can be congenital (genetic) or acquired (secondary to risk factors).

Purpose of the Study:

  • To review the molecular mechanisms underlying unregulated insulin secretion in hyperinsulinemic hypoglycemia.
  • To discuss genetic defects in key beta-cell genes associated with congenital HH.
  • To outline secondary causes and risk factors contributing to HH.

Main Methods:

  • Literature review of genetic and molecular studies on hyperinsulinemic hypoglycemia.
  • Analysis of known genetic mutations in nine genes implicated in congenital HH.
  • Compilation of clinical data on secondary causes of HH.

Main Results:

  • Genetic abnormalities in genes such as ABCC8, KCNJ11, GCK, and others cause congenital HH.
  • Perinatal factors, maternal diabetes, and developmental syndromes are linked to neonatal HH.
  • Insulinoma, non-insulinoma pancreatogenous hypoglycemia syndrome, and post-bariatric surgery are causes in older individuals.

Conclusions:

  • Molecular defects in beta-cell function are central to the pathogenesis of HH.
  • Understanding these mechanisms is crucial for diagnosing and managing HH.
  • Further research into genetic and acquired factors will improve therapeutic strategies for hypoglycemia.